These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 29758594)
1. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours. Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594 [TBL] [Abstract][Full Text] [Related]
2. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours. Hung YP; Lee JP; Bellizzi AM; Hornick JL Histopathology; 2017 Nov; 71(5):786-794. PubMed ID: 28640941 [TBL] [Abstract][Full Text] [Related]
3. LIN28A, a sensitive immunohistochemical marker for Embryonal Tumor with Multilayered Rosettes (ETMR), is also positive in a subset of Atypical Teratoid/Rhabdoid Tumor (AT/RT). Rao S; Rajeswarie RT; Chickabasaviah Yasha T; Nandeesh BN; Arivazhagan A; Santosh V Childs Nerv Syst; 2017 Nov; 33(11):1953-1959. PubMed ID: 28744687 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of paired-like homeobox 2b immunoexpression in pediatric brain tumors with embryonal morphology. Alturkustani M; Walker AD; Tran I; Snuderl M; Cotter JA Pathol Int; 2022 Aug; 72(8):402-410. PubMed ID: 35763016 [TBL] [Abstract][Full Text] [Related]
5. Utility of Phox2b immunohistochemical stain in neural crest tumours and non-neural crest tumours in paediatric patients. Warren M; Matsuno R; Tran H; Shimada H Histopathology; 2018 Mar; 72(4):685-696. PubMed ID: 28986989 [TBL] [Abstract][Full Text] [Related]
6. Brain and Spinal Cord Tumors of Embryonic Origin. Lampros M; Alexiou GA Adv Exp Med Biol; 2023; 1405():405-420. PubMed ID: 37452947 [TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of CRX in extracranial malignant small round cell tumors. Terry J; Calicchio ML; Rodriguez-Galindo C; Perez-Atayde AR Am J Surg Pathol; 2012 Aug; 36(8):1165-9. PubMed ID: 22790857 [TBL] [Abstract][Full Text] [Related]
8. PHOX2B immunolabeling: a novel tool for the diagnosis of undifferentiated neuroblastomas among childhood small round blue-cell tumors. Bielle F; Fréneaux P; Jeanne-Pasquier C; Maran-Gonzalez A; Rousseau A; Lamant L; Paris R; Pierron G; Nicolas AV; Sastre-Garau X; Delattre O; Bourdeaut F; Peuchmaur M Am J Surg Pathol; 2012 Aug; 36(8):1141-9. PubMed ID: 22790854 [TBL] [Abstract][Full Text] [Related]
9. Embryonal Tumors of the Central Nervous System with Multilayered Rosettes and Atypical Teratoid/Rhabdoid Tumors. Kamenova M; Kaneva R; Genova K; Gabrovsky N Adv Exp Med Biol; 2023; 1405():225-252. PubMed ID: 37452940 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow. Hata JL; Correa H; Krishnan C; Esbenshade AJ; Black JO; Chung DH; Mobley BC Arch Pathol Lab Med; 2015 Apr; 139(4):543-6. PubMed ID: 25822764 [TBL] [Abstract][Full Text] [Related]
11. C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center. Nambirajan A; Gurung N; Suri V; Sarkar C; Kumar A; Singh M; Sharma MC Childs Nerv Syst; 2021 Apr; 37(4):1067-1075. PubMed ID: 33236184 [TBL] [Abstract][Full Text] [Related]
12. Embryonal Tumors of the Central Nervous System: An Update. Blessing MM; Alexandrescu S Surg Pathol Clin; 2020 Jun; 13(2):235-247. PubMed ID: 32389264 [TBL] [Abstract][Full Text] [Related]
13. Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Träger C; Yáñez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Pöetschger U; Ladenstein R; Burchill SA Pediatr Blood Cancer; 2018 Jul; 65(7):e27052. PubMed ID: 29603574 [TBL] [Abstract][Full Text] [Related]
14. PHOX2B as a Reliable Marker for Neuroblastoma in Tissue and Cytology Specimens. Ma Y; Feng J; Zhao J; Ding D; Tian F; Chen L; Zheng J; Xiao X J Neuropathol Exp Neurol; 2021 Dec; 80(12):1108-1116. PubMed ID: 34965292 [TBL] [Abstract][Full Text] [Related]
15. Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas. Aboubakr O; Métais A; Maillard J; Hasty L; Brigot E; Berthaud C; Lacombe J; Pucelle N; Raynal J; Appay R; Varlet P; Tauziède-Espariat A Histopathology; 2024 Apr; 84(5):893-899. PubMed ID: 38253970 [TBL] [Abstract][Full Text] [Related]
16. TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes. Gessi M; Zur Muehlen A; Lauriola L; Gardiman MP; Giangaspero F; Pietsch T Neuropathol Appl Neurobiol; 2011 Jun; 37(4):406-13. PubMed ID: 21073496 [TBL] [Abstract][Full Text] [Related]
17. Supratentorial CNS-PNETs in children; a Swedish population-based study with molecular re-evaluation and long-term follow-up. Schepke E; Löfgren M; Pietsch T; Kling T; Nordborg C; Olsson Bontell T; Holm S; Öberg A; Nyman P; Eliasson-Hofvander M; Sabel M; Lannering B; Carén H Clin Epigenetics; 2023 Mar; 15(1):40. PubMed ID: 36895035 [TBL] [Abstract][Full Text] [Related]
18. Embryonal tumors in the WHO CNS5 classification: A Review. Gianno F; Miele E; Antonelli M; Giangaspero F Indian J Pathol Microbiol; 2022 May; 65(Supplement):S73-S82. PubMed ID: 35562137 [TBL] [Abstract][Full Text] [Related]
19. Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis. Krona C; Carén H; Sjöberg RM; Sandstedt B; Laureys G; Kogner P; Martinsson T Int J Oncol; 2008 Mar; 32(3):575-83. PubMed ID: 18292934 [TBL] [Abstract][Full Text] [Related]